
Natesto’s Impact on Glycemic Control in Diabetic American Males: A Clinical Study
Reading Time: 3 minutes Introduction The prevalence of type 2 diabetes among American males continues to rise, prompting ongoing research into effective management strategies. One emerging area of interest is the potential role of testosterone replacement therapy in glycemic control. Natesto, a novel intranasal testosterone gel, has been approved for the treatment of hypogonadism, but its effects on blood glucose levels in diabetic patients warrant further exploration. This article delves into a study examining the influence of Natesto on blood glucose levels in American males with type 2 diabetes, offering insights into its potential as an adjunct therapy for glycemic management. Study Design and...